Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leslie N. Aldrich is active.

Publication


Featured researches published by Leslie N. Aldrich.


ACS Chemical Biology | 2013

Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules

Stanley Y. Shaw; Khoa Tran; Adam B. Castoreno; Joanna M. Peloquin; Kara G. Lassen; Bernard Khor; Leslie N. Aldrich; Pauline H. Tan; Daniel B. Graham; Petric Kuballa; Gautam Goel; Mark J. Daly; Alykhan F. Shamji; Stuart L. Schreiber; Ramnik J. Xavier

Autophagy is an evolutionarily conserved catabolic process that directs cytoplasmic proteins, organelles and microbes to lysosomes for degradation. Autophagy acts at the intersection of pathways involved in cellular stress, host defense, and modulation of inflammatory and immune responses; however, the details of how the autophagy network intersects with these processes remain largely undefined. Given the role of autophagy in several human diseases, it is important to determine the extent to which modulators of autophagy also modify inflammatory or immune pathways and whether it is possible to modulate a subset of these pathways selectively. Here, we identify small-molecule inducers of basal autophagy (including several FDA-approved drugs) and characterize their effects on IL-1β production, autophagic engulfment and killing of intracellular bacteria, and development of Treg, TH17, and TH1 subsets from naïve T cells. Autophagy inducers with distinct, selective activity profiles were identified that reveal the functional architecture of connections between autophagy, and innate and adaptive immunity. In macrophages from mice bearing a conditional deletion of the essential autophagy gene Atg16L1, the small molecules inhibit IL-1β production to varying degrees suggesting that individual compounds may possess both autophagy-dependent and autophagy-independent activity on immune pathways. The small molecule autophagy inducers constitute useful probes to test the contributions of autophagy-related pathways in diseases marked by impaired autophagy or elevated IL-1β and to test novel therapeutic hypotheses.


Organic Letters | 2010

Evaluation of the Biosynthetic Proposal for the Synthesis of Marineosins A and B

Leslie N. Aldrich; Eric S. Dawson; Craig W. Lindsley

The first synthetic efforts toward marineosins A and B, novel spiroaminals from a Streptomyces actinomycete, are described by evaluation of the proposed biosynthesis. The hypothesized biosynthetic C1-C25 Diels-Alder substrate was prepared in 8 steps in 5.1% overall yield; however, the proposed biomimetic inverse-electron-demand hetero-Diels-Alder reaction failed to deliver the marineosin core. Molecular mechanics supports this observation.


Bioorganic & Medicinal Chemistry Letters | 2010

Total synthesis and biological evaluation of tambjamine K and a library of unnatural analogs

Leslie N. Aldrich; Sydney L. Stoops; Brenda C. Crews; Lawrence J. Marnett; Craig W. Lindsley

Herein we disclose the first total synthesis of tambjamine K and a library of unnatural analogs. Unnatural analogs were shown to be more potent in viability, proliferation, and invasion assays than the natural product in multiple cancer cell lines, with minimal to no cytotoxicity on non-transformed cell lines.


European Journal of Organic Chemistry | 2013

Towards the Total Synthesis of Marineosin A: Construction of the Macrocyclic Pyrrole and an Advanced, Functionalized Spiroaminal Model.

Leslie N. Aldrich; Cynthia B. Berry; Brittney S. Bates; Leah C. Konkol; Miranda So; Craig W. Lindsley

Herein, we describe the enantioselective construction of the 12-membered macrocyclic pyrrole core 4 of marineosin A in 5.1% overall yield from (S)-propylene oxide. The route features a key Stetter reaction to install a 1,4-diketone, which is then subjected to Paal-Knorr pyrrole synthesis and ring closing metathesis (RCM) to afford macrocycle 4. A divergence point in the synthetic scheme also enabled access to a highly functionalized spiroaminal model system 8 via an acid-mediated hydroxyketoamide cyclization strategy.


European Journal of Organic Chemistry | 2013

Towards the total synthesis of marineosin A

Leslie N. Aldrich; Cynthia B. Berry; Brittney S. Bates; Leah C. Konkol; Miranda So; Craig W. Lindsley

Herein, we describe the enantioselective construction of the 12-membered macrocyclic pyrrole core 4 of marineosin A in 5.1% overall yield from (S)-propylene oxide. The route features a key Stetter reaction to install a 1,4-diketone, which is then subjected to Paal-Knorr pyrrole synthesis and ring closing metathesis (RCM) to afford macrocycle 4. A divergence point in the synthetic scheme also enabled access to a highly functionalized spiroaminal model system 8 via an acid-mediated hydroxyketoamide cyclization strategy.


Journal of the American Chemical Society | 2015

Discovery of a Small-Molecule Probe for V-ATPase Function

Leslie N. Aldrich; Szu Yu Kuo; Adam B. Castoreno; Gautam Goel; Petric Kuballa; Matthew G. Rees; Brinton Seashore-Ludlow; Jaime H. Cheah; Isabel Latorre; Stuart L. Schreiber; Alykhan F. Shamji; Ramnik J. Xavier

Lysosomes perform a critical cellular function as a site of degradation for diverse cargoes including proteins, organelles, and pathogens delivered through distinct pathways, and defects in lysosomal function have been implicated in a number of diseases. Recent studies have elucidated roles for the lysosome in the regulation of protein synthesis, metabolism, membrane integrity, and other processes involved in homeostasis. Complex small-molecule natural products have greatly contributed to the investigation of lysosomal function in cellular physiology. Here we report the discovery of a novel, small-molecule modulator of lysosomal acidification derived from diversity-oriented synthesis through high-content screening.


Chemistry: A European Journal | 2018

Microwave-Assisted, Asymmetric Synthesis of 3-Amino-2,3-Dihydrobenzofuran Flavonoid Derivatives from Chalcones

Travis R. Helgren; Lianyan L. Xu; Daniel Sotelo; Yash R. Mehta; Melissa A. Korkmaz; Ivan Pavlinov; Leslie N. Aldrich

A route to access 3-amino-2,3-dihydrobenzofurans that utilizes microwave-assisted organic synthesis to rapidly generate analogues has been developed. The route begins with an acid-catalyzed, microwave-assisted aldol condensation to generate chalcone intermediates, followed by a Corey-Bakshi-Shibata reduction and subsequent Sharpless asymmetric epoxidation to access stereoisomeric epoxyalcohols. The final step is a one-pot, microwave-assisted, regioselective, acid-catalyzed epoxide opening with various amines followed by an intramolecular nucleophilic aromatic substitution reaction to generate the 3-amino-2,3-dihydrobenzofurans. This route provides ready access to stereochemically and structurally diverse analogues of these flavonoid scaffolds. Additionally, a pilot library was synthesized, and the biological activity diversity of the chalcones and dihydrobenzofurans was explored in human carcinoma cell lines.


Molecular Cancer Therapeutics | 2018

Phyllanthusmin derivatives induce apoptosis and reduce tumor burden in high-grade serous ovarian cancer by late-stage autophagy inhibition

Alexandria N. Young; Denisse Herrera; Andrew C. Huntsman; Melissa A. Korkmaz; Daniel D. Lantvit; Sarmistha Mazumder; Shamalatha Kolli; Christopher C. Coss; Salane King; Hongyan Wang; Steven M. Swanson; A. Douglas Kinghorn; Xiaoli Zhang; Mitch A. Phelps; Leslie N. Aldrich; James R. Fuchs; Joanna E. Burdette

High-grade serous ovarian cancer (HGSOC) is a lethal gynecological malignancy with a need for new therapeutics. Many of the most widely used chemotherapeutic drugs are derived from natural products or their semi-synthetic derivatives. We have developed potent synthetic analogues of a class of compounds known as phyllanthusmins, inspired by natural products isolated from Phyllanthus poilanei Beille. The most potent analogue, PHY34, had the highest potency in HGSOC cell lines in vitro and displayed cytotoxic activity through activation of apoptosis. PHY34 exerts its cytotoxic effects by inhibiting autophagy at a late stage in the pathway, involving the disruption of lysosomal function. The autophagy activator, rapamycin, combined with PHY34 eliminated apoptosis, suggesting that autophagy inhibition may be required for apoptosis. PHY34 was readily bioavailable through intraperitoneal administration in vivo where it significantly inhibited the growth of cancer cell lines in hollow fibers, as well as reduced tumor burden in a xenograft model. We demonstrate that PHY34 acts as a late-stage autophagy inhibitor with nanomolar potency and significant antitumor efficacy as a single agent against HGSOC in vivo. This class of compounds holds promise as a potential, novel chemotherapeutic and demonstrates the effectiveness of targeting the autophagic pathway as a viable strategy for combating ovarian cancer. Mol Cancer Ther; 17(10); 2123–35. ©2018 AACR.


Tetrahedron Letters | 2013

Spiroaminal model systems of the marineosins with final step pyrrole incorporation

Joseph D. Panarese; Leah C. Konkol; Cynthia B. Berry; Brittney S. Bates; Leslie N. Aldrich; Craig W. Lindsley


Tetrahedron Letters | 2009

MAOS protocols for the general synthesis and lead optimization of 3,6-disubstituted-[1,2,4]triazolo[4,3-b]pyridazines

Leslie N. Aldrich; Evan P. Lebois; L. Michelle Lewis; Natalia T. Nalywajko; Colleen M. Niswender; C. David Weaver; P. Jeffrey Conn; Craig W. Lindsley

Collaboration


Dive into the Leslie N. Aldrich's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Melissa A. Korkmaz

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexandria N. Young

University of Illinois at Chicago

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge